Oxime Derivative TFOBO Promotes Cell Death by Modulating Reactive Oxygen Species and Regulating NADPH Oxidase Activity in Myeloid Leukemia

Oxime Derivative TFOBO Promotes Cell Death by Modulating Reactive Oxygen Species and Regulating NADPH Oxidase Activity in Myeloid Leukemia

header-info
Here, we first tested a novel oxime-containing derivative of 2-((2,4,5-trifluorobenzyl)oxy)benzaldehyde oxime (TFOBO) to evaluate its anticancer effect in myeloid leukemic cells.